Use of evidence-based practice as a method for evaluating the effects of secretin on a child with autism

David M. Richman, R. Matthew Reese, Debora Daniels

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Standardized assessment instruments and direct observation data were collected pre-and postadministration (2 weeks after administration) on the effects of secretin on a 4-year-old boy diagnosed with autism. Information was collected on the three major diagnostic categories associated with autism: communication deficiencies, repetitive behavior and interests, and impaired social interactions. No changes in communication functioning, occurrences of stereotypic behavior, or social interaction were observed 2 weeks after administration of secretin. A 3-month follow-up interview with the child's primary care provider supported empirical data suggesting no substantial behavioral changes after the secretin administration. Results are discussed in terms of controversial treatments for children with autism and related developmental disorders.

Original languageEnglish
Pages (from-to)204-211
Number of pages8
JournalFocus on Autism and Other Developmental Disabilities
Volume14
Issue number4
DOIs
StatePublished - 1999

Fingerprint Dive into the research topics of 'Use of evidence-based practice as a method for evaluating the effects of secretin on a child with autism'. Together they form a unique fingerprint.

  • Cite this